Home >> CAP TODAY WEBINARS

CAP TODAY WEBINARS

Combining Clinical Signs and Symptoms with Histopathology for Definitive Diagnosis of Idiopathic Multicentric Castleman Disease (iMCD)

Webinar presenter Jade Neff, MD, PhD, Assistant Professor of Pathology, Duke University Medical Center, discusses Definitive Diagnosis of Idiopathic Multicentric Castleman Disease (iMCD), including the pivotal role that pathologists play in diagnosing iMCD, an elusive and debilitating disease that poses unique diagnostic challenges.

Read More »

Empowering Pathology Partnerships
for Growth & Rewards with GoPath

Webinar presenters Jim Lu, MD, PhD, CEO, Medical Director GoPath Diagnostics, and Kenneth Bloom, MD, Head of Pathology, Nucleai, discuss the future of partnerships between community-based pathology groups and (national) laboratories, including sub-specialty coverage, workload balancing, solutions in high-tech diagnostics, turnkey support for digital path and AI, and opportunities for more revenue and higher profits.

Read More »

Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients

Webinar presenters Alexander Craig MacKinnon, Jr, MD, PhD, Professor, Department of Pathology, University of Alabama at Birmingham, Darshan Chandrashekar, PhD, Assistant Professor, Department of Pathology-Genomic Diagnostics and Bioinformatics, University of Alabama at Birmingham, and Shuko Harada, MD, Professor, Department of Pathology-Genomic Diagnostics and Bioinformatics, University of Alabama at Birmingham, discuss rapid biomarker identification and how it promises more comprehensive approaches.

Read More »

HER2 Testing in Metastatic Colorectal Cancer (mCRC)


Webinar presenters Jaclyn Hechtman, MD, and John Marshall, MD, discuss how HER2 testing in mCRC opens a powerful new window for patients, testing methodology to identify HER2+ mCRC, a new treatment for patients with HER2+ mCRC, the importance of testing for HER2 in mCRC, and the efficacy and safety data from the MOUNTAINEER trial.

Read More »

Recommendations for reporting race free estimated glomerular filtration rate


Webinar presenter Greg Miller, PhD, Professor of Pathology, Director of Pathology Information Systems, Co-Director of Clinical Chemistry, Virginia Commonwealth University Health System, Richmond, Virginia, discusses why all labs should be using the 2021 CKD-EPI equations for eGFR from creatinine, how the new equations will standardize laboratory practice to improve patient care, and when and how follow up testing for CKD should be performed.

Read More »

IVD vs. RUO–Is Your Laboratory Relying on the Right Products? What you need to know to protect patients and your laboratory.

Webinar presenter Sebastian Gromminger, PhD, Strategic Expert in the field of in-vitro diagnostics with a focus on molecular genetic diagnostics, Consultant for the approval of in-vitro diagnostics, Johner Institut GmbH, discusses what the “Research Use Only” (RUO) label means and its consequences for medical laboratories, manufacturers, and patients.

Read More »

Post-transplant viral load monitoring: the importance of standardization and commutability of diagnostic methods

Webinar presenters Steve Miller, MD, PhD, University of California San Francisco, and Joseph Yao, MD, Mayo Clinic, Rochester, Minnesota, discuss the need for standardization in post-transplant diagnostics with emphasis on Epstein-Barr virus (EBV) and BK virus (BKV), how this can be achieved and how improvements in laboratory testing can potentially translate into better patient care, and the impact of COVID-19 on transplant diagnostics and laboratory testing and what this means for patients and for the laboratory. Moderated by: Bob McGonnagle, Publisher, CAP TODAY. This on-demand webinar originally broadcast November 5, 2020.

Read More »
CAP TODAY
X